Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?

Capecitabine, an oral pro-drug that is metabolized to 5-FU, has been used in clinical practice for more than 20 years, being part of the therapeutic standard for digestive and breast cancers. The use of capecitabine has been evaluated in many trials including cases diagnosed in recurrent or metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mireștean, Camil Ciprian, Iancu, Roxana Irina, Iancu, Dragoș Petru Teodor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573684/
https://www.ncbi.nlm.nih.gov/pubmed/36233450
http://dx.doi.org/10.3390/jcm11195582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573684/
https://www.ncbi.nlm.nih.gov/pubmed/36233450
http://dx.doi.org/10.3390/jcm11195582

Ejemplares similares